Comorbid depression and anxiety spectrum disorders

Depression and Anxiety

Volumn 4, Issue 4, 1996, Pages 160-168

  Gorman, Jack M ^a,b  

^a New York State Psychiatric Institute ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

anxiety; comorbidity; depression; generalized anxiety disorder; panic disorder; selective serotonin reuptake inhibitors; social phobia

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AMNESIA; ANXIETY NEUROSIS; ARTICLE; ATAXIA; COMORBIDITY; DEPRESSION; GENETICS; HUMAN; OBSESSION; PANIC; PRIORITY JOURNAL; PSYCHOTHERAPY; SOCIAL PHOBIA; SOMNOLENCE;

ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; COMORBIDITY; DEPRESSIVE DISORDER; HUMANS; TREATMENT OUTCOME;

EID: 0030434199     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6394(1996)4:4<160::AID-DA2>3.0.CO;2-J     Document Type: Article

References (85)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders. 4th edition (DSM-IV). Washington, DC: American Psychiatric Association, Inc, pp 723-725.
2. Amsterdam JD, Hornig-Rohan M, Maislin G (1994) Efficacy of alprazolam in reducing fluoxetine-induced jitteriness in patients with major depression. J Clin Psychiatry 55:394-400.
3. Andrade L, Eaton WW, Chilcoat H (1994) Lifetime comorbidity of panic attacks and major depression in a population-based study. Symptom profiles. Br J Psychiatry 165:363-369.
4. Angst J, Dobler-Mikola A (1985) The Zurich study: VI. A continuum from depression to anxiety disorders? Eur Arch Psychiatr Neurol Sci 235:179-186.
5. Barlow DH (1988) Anxiety and Its Disorders: Nature and Treatment of Anxiety and Panic. New York: Guilford Press.
6. Black DW, Wesner R, Bowers W, Gabel J (1993) A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Arch Gen Psychiatry 50:44-50.
7. Bowden RC, Kohout J (1979) The relationship between agoraphobia And primary affective disorders. Can J Psychiatry 24:317-321.
8. Breier A, Charney DS, Heninger GR (1984) Major depression in patients with agoraphobia and panic disorder. Arch Gen Psychiatry 41:1129-1135.
9. Breslau N, Davis GC (1985) Further evidence on the doubtful validity of generalized anxiety disorder. Psychiatry Res 16:177-179.
10. Brunello N, Langer SZ, Perez J, Racagni G (1994/1995) Current understanding of the mechanism of action of classic and newer antidepressant drugs. Depression 2:119-126.
11. Charney DS, Krystal JH, Delgado PL, Heninger GR (1990) Serotonin-specific drugs for anxiety and depressive disorders. Ann Rev Med 41:437-446.
12. Chen Y-W, Dilsaver SC (1995) Comorbidity of panic disorder in bipolar illness: Evidence from the Epidemiologic Catchment Area survey. Am J Psychiatry 152:280-282.
13. Chouinard G (1992) Sertraline in the treatment of obsessive-compulsive disorder: Two double-blind, placebo-controlled studies. Int Clin Psychopharmacol 7 (Suppl 2):37-41.
14. Clancy J, Noyes R Jr, Hoenk PR, Slymen DJ (1978) Secondary depressions in anxiety neurosis. J Nerv Ment Dis 16.846-850.
15. Clayton PJ (1990) The comorbidity factor: Establishing the primary diagnosis in patients with mixed symptoms of anxiety and depression. J Clin Psychiatry 51 (Suppl 11):35-39.
16. Cloninger CR (1990) Comorbidity of anxiety and depression. J Clin Psychopharmacol 10:43S-46S.
17. Coplan JD, Gorman JM, Klein DF (1992) Serotonin related functions in panic-anxiety: A critical overview. Neuropsychopharmacology 6:189-200.
18. Dealy RS, Ishiki DM, Avery DH, Wilson LG, Dunner DL (1981) Secondary depression in anxiety disorders. Compr Psychiatry 22:612-618.
19. den Boer JA, Westenberg HG, De Leeuw AS, van Vliet IM (1995) Biological dissection of anxiety disorders: The clinical role of selective serotonin reuptake inhibitors with particular reference to fluvoxamine. Int Clin Psychopharmacol 9 (Suppl 4):47-52.
20. De Wilde J, Spiers R, Mertens C, Bartholomé F, Schotte G, Leyman S (1993) A double-blind, comparative, multicenter study comparing paroxetine with fluoxetine in depressed patients. Acta Psychiatr Scand 87:141-145.
21. Dunner DL (1985) Anxiety and panic: Relationship to depression and cardiac disorders. Psychosomatics 26:18-21.
22. Eaton WW, Dryman A, Weissman MM (1991) Panic and phobia. In Robins LN, Regier DA (eds): Psychiatric Disorders in America. New York: Free Press, pp 155-179.
23. Eaton WW, Kessler RC, Wittchen HU, Magee WJ (1994) Panic and panic disorder in the United States. Am J Psychiatry 151:413-420.
24. Eison MS (1990) Serotonin: A common neurobiologic substrate in anxiety and depression. J Clin Psychopharmacol 10:26S-30S.
25. Evans MD, Hollon SD, DeRubeis RJ, Piasecki JM, Grove WM, Garvey MJ, Tuason VB (1992) Differential relapse following cognitive therapy and pharmacotherapy for depression. Arch Gen Psychiatry 49:802-808.
26. Fawcett J (1992) Suicide risk factors in depressive disorders and in panic disorder. J Clin Psychiatry 53 (Suppl 3):9-13.
27. Fawcett J, Kravitz HM (1983) Anxiety syndromes and their relationship to depressive illness. J Clin Psychiatry 44:8-11.
28. Fawcett J, Scheftner WA, Fogg L, Clark DC, Young MA, Hedeker D, Gibbons R (1990) Time-related predictors of suicide in major affective disorder. Am J Psychiatry 147.1189-1194.
29. Finley PR (1994) Selective serotonin reuptake inhibitors: Pharmacologic profiles and potential therapeutic distinctions. Ann Pharmacother 28:1359-1369.
30. Flint AJ (1994) Epidemiology and comorbidity of anxiety disorders in the elderly. Am J Psychiatry 151:640-649.
31. Greist JH, Jefferson JW, Koback KA, Katzelnick DJ, Serlin RC (1995) Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis. Arch Gen Psychiatry 52:53-60.
32. Grunhaus L, Harel Y, Krugler T, Pande AC, Haskett RF (1988) Major depressive disorder and panic disorder: Effects of comorbidity on treatment outcome with antidepressant medications. Clin Neuropharmacol 11:454-461.
33. Gulley LR, Nemeroff CB (1993) The neurobiological basis of mixed depression-anxiety states. J Clin Psychiatry 54 (Suppl 1):16-19.
34. Guy S, Silke B (1990) The electrocardiogram as a tool for therapeutic monitoring: A critical analysis. J Clin Psychiatry 51 (Suppl B):37-39.
35. Hamilton M (1983) The clinical distinction between anxiety and depression. Br J Clin Pharmacol 15:165S-169S.
36. Johnson J, Weissman MM, Klerman GL (1990) Panic disorder, Comorbidity, and suicide attempts. Arch Gen Psychiatry 47:805-808.
37. Johnson MR, Lydiard RB, Ballenger JC (1994) MAOIs in panic disorder and agoraphobia. In Kennedy SH (ed): Clinical Advances in Monoamine Oxidase Therapies. Washington, DC: American Psychiatric Press, pp 205-224.
38. Johnson MR, Lydiard RB, Ballenger JC (1995) Panic disorder: Pathophysiology and drug treatment. Drugs 49:328-344.
39. Kasper S, Lepine JP, Mendlewicz J, Montgomery SA, Rush JA Jr (1994/1995) Efficacy, safety, and indications for tricyclic and newer antidepressants. Depression 2:127-137.
40. Katon W, Hollifield M, Chapman T, Mannuzza S, Ballenger J, Fyer A (1995) Infrequent panic attacks: Psychiatric comorbidity, personality characteristics and functional disability. J Psychiatr Res 29:121-131.
41. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen H-U, Kendler KS (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 51:8-19.
42. Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M, Blazer DG (1996) Comorbidity of DSM-III-R major depressive disorder in the general population- Results from the U.S. National Comorbidity Survey. Br J Psychiatry 168 (Suppl 30):8-21.
43. Klein DF, Fink M (1962) Psychiatric reaction patterns to imipramine. Am J Psychiatry 119:432-438.
44. Klerman GL (1990) Depression and panic anxiety: The effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia. J Psychiatr Res 24 (Suppl 2):27-41.
45. Leckman JF, Weissman MM, Merikangas KR, Pauls DL, Prusoff BA (1983) Panic disorder increases risk for major depression, alcoholism, panic and phobic disorders in affectively ill families. Arch Gen Psychiatry 40:1055-1060.
46. Liebowitz MR (1993) Depression with anxiety and atypical depression. J Clin Psychiatry 54 (Suppl 2):10-14.
47. Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison W, Rabkin J, Tricamo E, Markowitz JS, Klein DF (1984) Phenelzine vs. imipramine in atypical depression. Arch Gen Psychiatry 41:669-677.
48. Liebowitz MR, Fyer AJ, Gorman JM, Campeas RB, Sandberg DP, Hollander E, Papp LA, Klein DF (1988) Tricyclic therapy of the DSM-III anxiety disorders: A review with implications for further research. J Psychiatr Res 22 (Suppl 1):7-31.
49. Liebowitz MR, Hollander E, Schneier F, Campeas R, Fallon B, Welkowitz L, Cloitre M, Davies S (1990) Anxiety and depression. Discrete diagnostic entities? J Clin Psychopharmacol 10:61S-66S.
50. Lydiard RB (1991) Coexisting depression and anxiety: Special diagnostic and treatment issues. J Clin Psychiatry 52 (Suppl 6):48-54.
51. Merikangas KR, Angst J (1995) Comorbidity and social phobia: Evidence from clinical, epidemiologic, and genetic studies. Eur Arch Psychiatry Clin Neurosci 244:297-303.
52. Mitchell PB (1994) Selective serotonin reuptake inhibitors: Adverse effects, toxicity, and interactions. Adverse Drug React Toxicol Rev 13:121-144.
53. Mountjoy CQ, Roth M (1982) Studies in the relationship between depressive disorders and anxiety states. J Affect Disord 4:127-147.
54. Munjack DJ, Moss HB (1981) Affective disorder and alcoholism in families of agoraphobics. Arch Gen Psychiatry 38:869-871.
55. Oehrberg S, Christiansen PE, Behnke K, Borup AL, Severin B, Soegaard J, Calberg H, Judge R, Ohrstrom JK, Manniche PM (1995) Paroxetine in the treatment of panic disorder: A randomized, double-blind, placebo-controlled study. Br J Psychiatry 167:374-379.
56. Paul SM (1988) Anxiety and depression: A common neurobiological substrate? J Clin Psychiatry 49 (Suppl 10):13-16.
57. Pava JA, Fava M, Levenson JA (1994) Integrating cognitive therapy and pharmacotherapy in the treatment and prophylaxis of depression: A novel approach. Psychother Psychosom 61:211-219.
58. Pecknold JC (1993) Discontinuation reactions to alprazolam in panic disorder. J Psychiatr Res 27 (Suppl 1):155-170.
59. Piccinelli M, Pini S, Bellantuono C, Wilkinson G (1995) Efficacy of drug treatment in obsessive-compulsive disorder: A meta-analytic review. Br J Psychiatry 166:424-443.
60. Rasmussen SA, Eisen JL (1992) The epidemiology and differential diagnosis of obsessive compulsive disorder. J Clin Psychiatry 53 (Suppl 4):4-10.
61. Regier DA, Boyd JH, Burke JD Jr, Rae DS, Myers JK, Kramer M, Robins W, George LK, Karno M, Locke BZ (1988) One-month prevalence of mental disorders in the United States: Based on five epidemiologic catchment area sites. Arch Gen Psychiatry 45:977-986.
62. Rickels K, Schweizer E (1993) The treatment of generalized anxiety disorder in patients with depressive symptomatology. J Clin Psychiatry 54 (Suppl 1):20-23.
63. Rickels K, Schweizer E, Weiss S, Zavodnick S (1993) Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper Arch Gen Psychiatry 50:61-68.
64. Robinson DS, Kayser A, Corcella J, Laux D, Yingling K, Howard D (1985) Panic attacks in outpatients with depression: Response to antidepressant treatment. Psychopharmacol Bull 21:562-567.
65. Roth M, Gurney C, Garside RF, Kerr TA (1972) Studies in the classification of affective disorders: The relationship between anxiety states and depressive illness. Br J Psychiatry 121:147-161.
66. Roy-Byrne PP, Uhde TW, Post RM, Gallucci W, Chrousos GP, Gold PW (1986) The corticotropin-releasing hormone stimulation test in patients with panic disorder. Am J Psychiatry 143:896-899.
67. Roy-Byrne PP, Sullivan MD, Cowley DS, Ries RK (1993) Adjunctive treatment of benzodiazepine discontinuation syndromes: A review. J Psychiatr Res 27 (Suppl 1):143-153.
68. Schatzberg AF (1995) Fluoxetine in the treatment of comorbid anxiety and depression. J Clin Psychiatry Monogr 13:2-12.
69. Schneier FR, Liebowitz MR, Davies SO, Fairbanks J, Hollander E, Campeas R, Klein DF (1990) Fluoxetine in panic disorder. J Clin Psychopharmacol 10:119-121.
70. Shaw BF (1989) Cognitive-behavioral therapies for major depression: Current status with an emphasis on prophylaxis. Psychiatr J Univ Ottawa 14:403-412.
71. Shelton RC, Harvey DS, Stewart PM, Loosen PT (1993) Alprazolam in panic disorder: A retrospective analysis. Prog Neuropsychopharmacol Biol Psychiatry 17:423-434.
72. Stahl SM (1993) Mixed anxiety and depression: Clinical implications. J Clin Psychiatry 54 (Suppl 1):33-38.
73. Stein MB, Tancer ME, Uhde TW (1990) Major depression in patients with panic disorder: Factors associated with course and recurrence. J Affect Disord 19:287-296.
74. Targum SD (1990) Differential responses to anxiogenic challenge studies in patients with major depression disorder and panic disorder. Biol Psychiatry 28:21-34.
75. van Valkenburg C, Akiskal HS, Puzantian V (1984) Anxious depressions: clinical, family history, and naturalistic outcome: Comparisons with panic and major depressive disorders. J Affect Disord 6.67-82.
76. van Vliet IM, den Boer JA, Westenberg HG (1992) Psychopharmacological treatment of social phobia: Clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor. Eur Neuropsychopharmacol 2:21-29.
77. van Vliet IM, Westenberg HG, den Boer JA (1993) MAO inhibitors in panic disorder: Clinical effects of treatment with brofaromine. A double-blind, placebo-controlled study. Psychopharmacology 112:483-489.
78. Vollrath M, Angst J (1989) Outcome of panic and depression in a seven-year follow-up: Results of the Zurich study. Acta Psychiatr Scand 80:591-596.
79. Westenberg HG, den Boer JA (1993) New findings in the treatment of panic disorder. Pharmacopsychiatry 26 (Suppl 1):30-33.
80. Wetzler S, Katz MM (1989) Problems with the differentiation of anxiety and depression. J Psychiatr Res 23:1-12.
81. Wittchen H-U, Essau CA (1993) Comorbidity and mixed anxietydepressive disorders: Is there epidemiologic evidence? J Clin Psychiatry 54 (Suppl 1).9-15.
82. Wittchen H-U, Knauper B, Kessler RC (1994a) Lifetime risk of depression. Br J Psychiatry 165 (Suppl 26):16-22.
83. Wittchen H-U, Zhao S, Kessler RC, Eaton WW (1994b) DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch Gen Psychiatry 51:355-364.
84. Woodruff RA, Guze SB, Clayton PJ (1972) Anxiety neurosis among psychiatric outpatients. Compr Psychiatry 13: 165-170.
85. Zajecka JM, Ross JS (1995) Management of comorbid anxiety and depression. J Clin Psychiatry 56 (Suppl 2):10-13.